School of Health Sciences, University of Surrey, Guilford, UK.
School of Nursing, University of California, San Francisco, California, USA.
J Pain Symptom Manage. 2018 Feb;55(2):318-333.e4. doi: 10.1016/j.jpainsymman.2017.08.020. Epub 2017 Aug 30.
Risk profiling of oncology patients based on their symptom experience assists clinicians to provide more personalized symptom management interventions. Recent findings suggest that oncology patients with distinct symptom profiles can be identified using a variety of analytic methods.
The objective of this study was to evaluate the concordance between the number and types of subgroups of patients with distinct symptom profiles using latent class analysis and K-modes analysis.
Using data on the occurrence of 25 symptoms from the Memorial Symptom Assessment Scale, that 1329 patients completed prior to their next dose of chemotherapy (CTX), Cohen's kappa coefficient was used to evaluate for concordance between the two analytic methods. For both latent class analysis and K-modes, differences among the subgroups in demographic, clinical, and symptom characteristics, as well as quality of life outcomes were determined using parametric and nonparametric statistics.
Using both analytic methods, four subgroups of patients with distinct symptom profiles were identified (i.e., all low, moderate physical and lower psychological, moderate physical and higher Psychological, and all high). The percent agreement between the two methods was 75.32%, which suggests a moderate level of agreement. In both analyses, patients in the all high group were significantly younger and had a higher comorbidity profile, worse Memorial Symptom Assessment Scale subscale scores, and poorer QOL outcomes.
Both analytic methods can be used to identify subgroups of oncology patients with distinct symptom profiles. Additional research is needed to determine which analytic methods and which dimension of the symptom experience provide the most sensitive and specific risk profiles.
基于患者的症状体验对肿瘤患者进行风险评估有助于临床医生提供更个性化的症状管理干预措施。最近的研究结果表明,使用各种分析方法可以识别出具有不同症状特征的肿瘤患者。
本研究旨在评估使用潜在类别分析和 K-模式分析识别具有不同症状特征的患者亚组数量和类型的一致性。
使用 1329 名患者在接受下一次化疗(CTX)前完成的 Memorial Symptom Assessment Scale 上发生的 25 种症状的数据,使用 Cohen's kappa 系数评估两种分析方法之间的一致性。对于潜在类别分析和 K-模式,使用参数和非参数统计方法确定亚组在人口统计学、临床和症状特征以及生活质量结果方面的差异。
使用两种分析方法,确定了具有不同症状特征的四个患者亚组(即所有低、中度身体和较低心理、中度身体和较高心理、以及所有高)。两种方法之间的百分比一致性为 75.32%,表明存在中等程度的一致性。在两种分析中,所有高组的患者明显更年轻,合并症谱更高,Memorial Symptom Assessment Scale 子量表评分更差,生活质量结果更差。
两种分析方法均可用于识别具有不同症状特征的肿瘤患者亚组。需要进一步研究以确定哪种分析方法和症状体验的哪个维度提供最敏感和特异的风险特征。